Effect of PI3K/AKT Pathway on Cisplatin Resistance in Non-small Cell Lung Cancer

Effect of PI3K/AKT Pathway on Cisplatin Resistance in Non-small Cell Lung Cancer

Accumulating evidences indicate that aberrant activation of PI3K/AKT pathway in non-small cell lung cancer plays a vital role in tumor cell proliferation,apoptosis, and survival including drug resistance. Cisplatin as first-line chemotherapy are in widespread clinical use in patients with non-small...

Full description

Bibliographic Details
Main Authors: Yu ZHANG, Hongling LU, Gang XU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2014-08-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
PI3k/AKT pathway
Cisplatin
Resistance
Molecular mechanisms
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2014.08.09

Similar Items

Similar Items